<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR10">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>London</surname>
    <given-names>WB</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials</article-title>
  <source>Cancer</source>
  <year>2017</year>
  <volume>123</volume>
  <fpage>4914</fpage>
  <lpage>4923</lpage>
  <pub-id pub-id-type="doi">10.1002/cncr.30934</pub-id>
  <?supplied-pmid 28885700?>
  <pub-id pub-id-type="pmid">28885700</pub-id>
 </element-citation>
</ref>
